April 30, 2013

New horizons in allergy diagnostics and treatment



New horizons in allergy diagnostics and treatment

RafaƂ
Pawliczak
Pol Arch Med Wewn
2013
pii: AOP_13_020
PMID: 
23611954
Published online: 
April 24, 2013


tabs-grup

According to several studies both doctors and patients impatiently awaiting new treatments for allergic diseases. After anti-leukotrienes and omalizumab introduction to asthma treatment, no new class of drugs was registered for use. Drug development in allergy covers several pathways. Most of them are promising. In this review some aspects of new drugs development were discussed. New class of drugs such as cytokine antagonists, kinase inhibitors, transcription factors antagonists are close to come. Moreover, new anti IgE antibodies and PDE4 inhibitors are also under development. Some useful diagnostic tool have been already introduced. Unfortunately, no preventive options allowing for sensitization prophylaxis are available.
Key words 
asthma, allergy, new treatment
s

No comments:

Post a Comment